179 related articles for article (PubMed ID: 17969361)
1. [ALS and neurotrophic factors--HGF as a novel neurotrophic and neuroregenerative factor].
Funakoshi H; Ohya W; Kadoyama K; Nakamura T
Brain Nerve; 2007 Oct; 59(10):1195-202. PubMed ID: 17969361
[TBL] [Abstract][Full Text] [Related]
2. [Neurotrophic factors and amyotrophic lateral sclerosis (ALS)--therapeutic potential of a new neurotrophic factor: HGF in ALS].
Funakoshi H; Nakamura T
No To Shinkei; 2003 Oct; 55(10):841-5. PubMed ID: 14635512
[No Abstract] [Full Text] [Related]
3. [Gene therapy and neurotrophic factor treatment for amyotrophic lateral sclerosis].
Abe K; Manabe Y; Murakami T
Rinsho Shinkeigaku; 2001 Dec; 41(12):1160-1. PubMed ID: 12235826
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS.
Kadoyama K; Funakoshi H; Ohya W; Nakamura T
Neurosci Res; 2007 Dec; 59(4):446-56. PubMed ID: 17935811
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic mechanisms in amyotrophic lateral sclerosis.
Sandyk R
Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147
[TBL] [Abstract][Full Text] [Related]
6. Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery.
Lunn JS; Hefferan MP; Marsala M; Feldman EL
Growth Factors; 2009 Jun; 27(3):133-40. PubMed ID: 19294549
[TBL] [Abstract][Full Text] [Related]
7. [Hepatocyte growth factor therapy for amyotrophic lateral sclerosis].
Aoki M
Brain Nerve; 2012 Mar; 64(3):245-54. PubMed ID: 22402718
[TBL] [Abstract][Full Text] [Related]
8. [Development of motor neuron restorative therapy in amyotrophic lateral sclerosis using hepatocyte growth factor].
Aoki M; Warita H; Suzuki N; Itoyama Y
Rinsho Shinkeigaku; 2009 Nov; 49(11):814-7. PubMed ID: 20030218
[TBL] [Abstract][Full Text] [Related]
9. [Animal models of amyotrophic lateral sclerosis].
Yamanaka K
Rinsho Shinkeigaku; 2007 Nov; 47(11):934-7. PubMed ID: 18210840
[TBL] [Abstract][Full Text] [Related]
10. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
Turner BJ; Talbot K
Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
[TBL] [Abstract][Full Text] [Related]
11. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice.
Tanaka K; Okada Y; Kanno T; Otomo A; Yanagisawa Y; Shouguchi-Miyata J; Suga E; Kohiki E; Onoe K; Osuga H; Aoki M; Hadano S; Itoyama Y; Ikeda JE
Exp Neurol; 2008 Jun; 211(2):378-86. PubMed ID: 18423451
[TBL] [Abstract][Full Text] [Related]
12. [Neurotrophins. II: therapeutic potential].
Zazpe A; Del Río J
Rev Med Univ Navarra; 1997; 41(3):180-4. PubMed ID: 10420924
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model.
Ishigaki A; Aoki M; Nagai M; Warita H; Kato S; Kato M; Nakamura T; Funakoshi H; Itoyama Y
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1037-44. PubMed ID: 17984685
[TBL] [Abstract][Full Text] [Related]
14. Motoneuron cell death and neurotrophic factors: basic models for development of new therapeutic strategies in ALS.
Beck M; Karch C; Wiese S; Sendtner M
Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar; 2 Suppl 1():S55-68. PubMed ID: 11465926
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS.
Sun W; Funakoshi H; Nakamura T
J Neurosci; 2002 Aug; 22(15):6537-48. PubMed ID: 12151533
[TBL] [Abstract][Full Text] [Related]
16. Expression of hepatocyte growth factor in the skin of amyotrophic lateral sclerosis.
Nomura M; Oketa Y; Yasui K; Ishikawa H; Ono S
Acta Neurol Scand; 2012 Jun; 125(6):389-97. PubMed ID: 21824113
[TBL] [Abstract][Full Text] [Related]
17. [Amyotrophic lateral sclerosis].
Moriwaka F
Hokkaido Igaku Zasshi; 1997 Jan; 72(1):21-5. PubMed ID: 9086359
[TBL] [Abstract][Full Text] [Related]
18. [Neurotrophic factor treatment in amyotrophic lateral sclerosis].
Tsuzaka K; Mitsumoto H
No To Shinkei; 1998 Jul; 50(7):625-30. PubMed ID: 9739520
[No Abstract] [Full Text] [Related]
19. VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice.
Zheng C; Sköld MK; Li J; Nennesmo I; Fadeel B; Henter JI
Biochem Biophys Res Commun; 2007 Nov; 363(4):989-93. PubMed ID: 17923114
[TBL] [Abstract][Full Text] [Related]
20. Experimental models of amyotrophic lateral sclerosis.
Elliott JL
Neurobiol Dis; 1999 Oct; 6(5):310-20. PubMed ID: 10527800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
